Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
January 18, 2012 | NPR · Morning Edition gives its audience news, analysis, commentary, and coverage of arts and sports. Stories are told through conversation as well as full reports. It's up-to-the-minute news that prepares listeners for the day ahead.
 
July 30, 2014 | KQED · Adding a translation to the English label would require bigger bottles, pharmacists say. They worry patients would wind up carrying a few pills around loose — without any instructions at all.
 
July 30, 2014 | WNYC · In the past 20 years, New Jersey went from having more than 20 percent of U.S. pharmaceutical manufacturing jobs to less than 10 percent. That means offices, labs and warehouses have gone dark.
 

Latest program rundown

Coming up:

Latest Features:
July 30, 2014 | NPR · An explosion rocked a crowded Gaza market during what was expected to be a lull in the fighting. Earlier in the day a United Nations school was hit by what U.N. officials say was Israeli artillery fire, killing at least 15 people. Meanwhile, rocket fire from Gaza continues to be fired into Israel.
 
July 30, 2014 | NPR · Federal Reserve policymakers are announcing that the Fed plans to leave short-term interest rates at a level near zero. This, despite an economy that grew at a surprisingly strong 4 percent annual rate in the most recent quarter.
 
July 30, 2014 | NPR · Wildfires are ravaging thousands of square miles on the West Coast, though officials say that this wildfire season has been tamer than average. Still, responding to these fires has proven costly, and the Obama administration is reevaluating how it pays for fighting them.
 

Latest Saturday rundown




WE Saturday Feature

July 26, 2014 | NPR · Hezbollah has been a longtime ally of Hamas, but during this most recent conflict between Israel and Gaza they've taken a sideline role. NPR's Scott Simon talks to the BBC's Kim Ghattas in Beirut.
 

Latest Sunday rundown


WE Sunday Feature

July 27, 2014 | NPR · Fighting in Ukraine near the crash site of Malaysia Airlines Flight MH17 has international investigators staying away. NPR's Arun Rath talks with OSCE's Michael Bociurkiw about the investigation.
 

Latest program rundown

Coming up:

Pharmaceuticals

Jul 25, 2014 — A husband and wife who are doctors have been working on fact boxes for drugs that, like nutrition labels for foods, would more concisely convey a medicine's benefits and risks.
Launch in player | Comments |
Jul 11, 2014 — There's overmedicating and self-medicating, but some vets are "de-medicating." Prescribed multiple drugs to deal with PTSD and pain, they've stopped taking them — without authorization.
Launch in player | Comments |
Jun 23, 2014 — Drugmakers offer medicines at a bargain price to hospitals that treat large numbers of poor patients. Hospitals sometimes resell the drugs at full price and make hefty profits.
Launch in player | Comments |
May 20, 2014 — Medicare gives itself the power to ban doctors if they prescribe medications in abusive ways. The action follows a ProPublica series that found inappropriate prescribing, waste and fraud.
Comments |
May 16, 2014 — The Food and Drug Administration's approval of a new drug for leishmaniasis came with a voucher that can be redeemed to speed up the approval of a much more lucrative drug in the future.
Comments |
May 12, 2014 — Once a drug is approved by the FDA, doctors can use it as they see fit. That can be brilliant or risky, depending on the medication and the patient.
Launch in player | Comments |
May 6, 2014 — German drug company Bayer makes a deal with U.S.-based Merck & Co. The purchase includes brands such as Claritin, Coppertone and Dr. Scholl's.
Comments |
Apr 28, 2014 — Pfizer, founded in Brooklyn, N.Y., in 1849, would become a British company by combining with AstraZeneca. The new company would get a much lower tax rate by moving its legal headquarters overseas.
Comments |
Apr 23, 2014 — Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical success comes at a high price.
Comments |
Apr 8, 2014 — New drugs are usually tested in animals before they're tested in humans. But many of those studies aren't done carefully enough, analysts say. So time and money is wasted, and treatments are delayed.
Launch in player | Comments |
more Pharmaceuticals from NPR